Substituted pyrazoles as IRAK inhibitors
US10314841B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2015 |
| Grant date | Jun 11, 2019 |
| Priority date | — |
| Expiry date | Jul 30, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (II) for the treatment of cancer, rheumatoid arthritis and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.